These alterations contribute to oncogenic processes by disrupting normal TP53-mediated cellular functions, thereby promoting cancer development and progression.The identification of R273C, G105C, G266E, Q136H/P, and R280G as driver mutations underscores their pivotal role in cancer pathogenesis. This evidence concerns the gene TP53 and cancer.